Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
about
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer.Basal-like and triple-negative breast cancers: searching for positives among many negativesRefined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia.Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA.Clinicopathological and Molecular Study of Triple-Negative Breast Cancer in Algerian Patients.Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients.Hereditary breast cancer syndromes and genetic testing.Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer.A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.The expression of APE1 in triple-negative breast cancer and its effect on drug sensitivity of olaparib.New agents for the management of resistant metastatic breast cancer.Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.Precision medicine based on tumorigenic signaling pathways for triple-negative breast cancerA multi-institutional study on the association between BRCA1/BRCA2 mutational status and triple-negative breast cancer in familial breast cancer patients
P2860
Q33915040-CC3B9CE4-C47D-43AF-AC41-FFFC1A616433Q35005793-7E6D436E-E77B-4518-9653-E4AB2259D1D5Q35155449-4FBD7F9B-0925-4440-ABC2-F7451C82AD3CQ36087198-78FFF629-69FA-4D2F-827C-23175F4F53E7Q36365067-8E9CCDC8-E36E-43FB-A064-B794654E5BABQ37367870-1AD9429C-DA8F-46A9-A68A-392DDF839AA6Q38266306-265E9DD5-B29D-44DD-B579-7F94F9294B9CQ38691342-6C07614F-6E72-4656-BA8B-6FF24A6950FAQ41740523-76FF58E3-C4B9-4657-87B4-F47F2DFE8219Q42181679-8C3EA992-5B14-421B-9737-CD63424A7750Q42491917-249B316A-DE74-4AE5-823E-2721956D4E84Q47416545-894A91CE-5A82-4093-AF39-AAC888364156Q48240854-652EC03B-B506-497D-B045-6DD81FF73D6DQ52808311-CA7D73AE-EBBC-4D20-8CCC-B81D3DB45707Q57105411-6DB3AAE1-DDBD-43FD-BA35-01B6BBE32784Q58096003-3BDD9AB6-6AEF-4F4D-9D59-348E09180850
P2860
Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@en
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@nl
type
label
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@en
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@nl
prefLabel
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@en
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@nl
P2093
P2860
P1476
Evaluation of BRCA1 mutations ...... triple-negative breast cancer.
@en
P2093
Craig D Shriver
Erika Varner
Rachel E Ellsworth
Seth Rummel
P2860
P2888
P304
P356
10.1007/S10549-012-2348-2
P407
P577
2012-11-29T00:00:00Z